Equipment and utensils are not maintained at appropriate intervals to prevent malfunctions and contamination that would alter the safety, identity, strength, quality or purity of the drug product.
Inspection Record
Tropical Seas, Inc. — FDA 483 Findings
Inspectors Saundrea A MunroeThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
The written record did not include the reason an investigation was found not to be necessary when an investigation into unexplained discrepancies was not conducted.
There are no written procedures for production and process controls designed to assure that the drug products have the identity, strength, quality, and purity they purport or are represented to possess.
Each component is not added to the batch by one person and verified by a second person..
Written procedures are not followed that describe the in-process controls and examinations to be conducted on appropriate samples of in-process materials of each batch.
Laboratory records do not include a complete record of all data secured in the course of each test, including all graphs, charts and spectra from laboratory instrumentation, properly identified to show the specific component and drug product tested.
Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that components and drug products conform to appropriate standards of identity, strength, quality and purity.
Employees are not given training in the particular operations they perform as part of their function and written procedures required by current good manufacturing practice regulations.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Mylan Laboratories Limited2026-05-15 · US FDASimilar to finding 1 Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent malfunctions and contamination that would alter the safety, identity…
- Eugia Pharma Specialities Limited2025-11-14 · US FDASimilar to finding 1 Equipment and utensils are not cleaned, sanitized at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or…
- Bausch and Lomb, Inc2015-07-24 · US FDASimilar to finding 3 There are no written procedures for production and process controls designed to ensure that the drug products have the identity, strength, quality, and purity…
- OPS International Inc dba Olympia Pharmaceuticals2026-09-03 · US FDASimilar to finding 4 Each component is not added to the batch by one person and verified by a second person ..
- DNA Pharmacy Services Inc dba Palm Beach Compounding2015-07-17 · US FDASimilar to finding 1 Equipment and utensils are not maintained at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity…
A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.